Experience and qualifications
Michael Meng is a Principal in the Healthcare Group. He joined Apax Partners in 2008 and is currently based in New York. He is involved in a number of key deals including most recently Vyaire Medical, Ideal Protein, GENEX, and One Call Care Management. In addition, his past Apax deal experience includes TriZetto, Qualitest Pharmaceuticals, and rue21.
Prior to joining Apax Partners, Michael was a member of Lazard's Healthcare Mergers & Acquisitions Group in New York, where he worked on pharma, biotech, and healthcare services M&A and financing transactions. He has also worked in investment banking in Hong Kong office of UBS.
Michael holds an MBA in Healthcare Management from The Wharton School of the University of Pennsylvania and a BBA in Finance and Accounting from the Ross School of Business at the University of Michigan.
Investments
Investments include:
Ideal Protein
A leading provider of weight loss solutions in North America
GENEX
Leading US provider of integrated managed care services
One Call Care Management
Market-leading US providers of medical cost-containment solutions
Qualitest Pharmaceuticals
Manufacturer and distributor of generic pharmaceuticals in the US
rue21, Inc.
rue21 is a leading specialty retailer of value-priced apparel for ages ranging from pre-teens to mid-thirties
The Trizetto Corporation
Leading supplier of software and related services to health plans and other healthcare payers
Vyaire Medical
Global leader in the respiratory diagnostics, ventilation, and anesthesia delivery & patient monitoring market segments
Current directorships
Ideal Protein
A leading provider of weight loss solutions in North America